64
14
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8849 |
PF-9601N
|
MAO | Metabolism; Neuroscience |
PF-9601N 是一种单胺氧化酶 B (MAO-B) 抑制剂,在多种体内外模型中表现出抗帕金森病 (PD) 的神经保护作用。它可用于研究兴奋性毒性介导的神经退行性疾病。 | |||
T22605 |
Bifemelane hydrochloride
|
MAO; Monoamine Oxidase | Metabolism; Neuroscience |
Bifemelane hydrochloride 是一种选择性的,有效的,和竞争性的单胺氧化酶A (MAO-A)抑制剂,Ki=4.20 μM,它也非竞争性地抑制MAO-B,Ki=46.0 μM。它具有显著的抗抑郁作用,可用于研究与脑血管疾病有关的认知和情绪障碍。 | |||
T7626 |
Budipine
|
Others | Others |
Budipine 是抗帕金森病剂的一种。 | |||
T18918 |
Azure B
Azure B chloride,天青 B |
MAO; Monoamine Oxidase | Metabolism; Neuroscience |
Azure B (Azure B chloride) 是一种 Methylene blue 的主要代谢物,是一种阳离子染料,用于 Azure 曙红染色剂以进行血液涂片染色。它是高选择性和可逆的抑制单胺氧化酶(MAO)-A 的抑制剂,对重组人的 MAO-A 和 MAO-B 的IC50分别为 11 和 968 nM。它具有显著的抗抑郁作用。 | |||
T1993 |
J-147
J147 |
Epigenetic Reader Domain; Dopamine Receptor; Monoamine Oxidase | Chromatin/Epigenetic; GPCR/G Protein; Neuroscience |
J-147 是一种高效的、具有口服活性的、可透过血脑屏障神经保护剂,可增强认知能力。它抑制单胺氧化酶 B 和多巴胺转运体,EC50分别为 1.88 μM 和 0.649 μM。它有研究阿尔茨海默氏症的潜力。 | |||
T0300 |
Pargyline
Pargylamine,Paragyline,优降宁 |
MAO; Monoamine Oxidase | Metabolism; Neuroscience |
Pargyline (Pargylamine) 是不可逆的单胺氧化酶抑制剂,对MAO-A 和MAO-B 的Ki 分别为 13 μM 和 0.5 μM,具有降压和抗癌作用。 | |||
T6073 |
OG-L002
|
Histone Demethylase; Monoamine Oxidase; HSV | Chromatin/Epigenetic; Microbiology/Virology; Neuroscience |
OG-L002 是一种高度选择性的 LSD1有效抑制剂,IC50为 0.02 μM。它抑制HSV IE 基因的表达,还是单胺氧化酶抑制剂,对 MAO-A 和 MAO-B 的IC50分别为 1.38 μM 和 0.72 μM。 | |||
T1578 |
Pargyline hydrochloride
优降宁盐酸盐,Pargylamine hydrochloride |
MAO; Monoamine Oxidase | Metabolism; Neuroscience |
Pargyline hydrochloride (Pargylamine hydrochloride) 是不可逆的单胺氧化酶抑制剂,可作用于 MAO-A (Ki=13 μM) 和 MAO-B (Ki=0.5 μM) ,具有降压和抗癌作用。 | |||
T60806 | Monoamine Oxidase B inhibitor 2 | ||
Monoamine Oxidase B inhibitor 2 是有可逆并且口服有效的和选择性的单胺氧化酶 B (MAO-B) 抑制剂(IC50 = 1.33 nM) ,可以透过血脑屏障 (BBB)。Monoamine Oxidase B inhibitor 2 显示出抗氧化和抗神经炎症活性,可用于研究帕金森病。 | |||
T60656 | Monoamine Oxidase B inhibitor 1 | ||
Monoamine Oxidase B inhibitor 1 是一种可逆、口服有效和选择性的单胺氧化酶 B 抑制剂 (IC50 = 0.02 nM),可以穿过血脑屏障 (BBB)。Monoamine Oxidase B inhibitor 1 显示出抗氧化和抗神经炎症活性,可用于研究帕金森病。 | |||
T67850 |
FCE 28073
|
MAO | Metabolism; Neuroscience |
FCE 28073是一种 Monoamine oxidase B 抑制剂,IC50=0.45 μM。 | |||
T10079 |
MAO-IN-1
|
MAO | Metabolism; Neuroscience |
MAO-IN-1是一种高效的单胺氧化酶B (MAO B)抑制剂(IC50:20 nM),可用于研究神经系统相关疾病。 | |||
T67789 |
Bazinaprine
|
MAO | Metabolism; Neuroscience |
Bazinaprine 是一种选择性的、可逆的单胺氧化酶抑制剂(MAOI),是治疗抑郁症的候选化合物。Bazinaprine 对A 型单胺氧化酶显示出较强的抑制作用,对b 型单胺氧化酶只显示出较弱的抑制作用。Bazinaprine 在体内可逆,但在体外不可逆。 | |||
T77564 |
Coumarin102
Exciton 480 |
||
Coumarin102 (Exciton 480)是一种荧光染料。Coumarin102对Monoamine oxidase B、MAO-B和MAO-A具有较弱的抑制活性,可用来研究神经系统疾病。 | |||
T24680 |
PSB-1491
|
MAO | Metabolism; Neuroscience |
PSB-1491 是一种选择性和竞争性的单胺氧化酶 B 抑制剂,IC50 为 0.386 nM,是 MAO-A 的 25000 倍以上。 | |||
T24679 |
PSB-1434
PSB 1434,PSB1434 |
MAO | Metabolism; Neuroscience |
PSB-1434 是一种选择性和竞争性的单胺氧化酶 B 抑制剂,IC50 为 1.59 nM,相对于 MAO-A 的选择性>6000 倍。 | |||
T60712 |
MAO-B-IN-17
|
MAO | Metabolism; Neuroscience |
MAO-B-IN-17 是一种具有选择性和有效性的单胺氧化酶 B (MAO-B) 抑制剂(IC50:5.08 μM),可用于研究像帕金森类的中枢神经系统疾病。 | |||
T67764 |
hMAO-B-IN-4
|
MAO | Metabolism; Neuroscience |
hMAO-B-IN-4 (compound B10) 是一种选择性的、可逆的、血脑屏障通透性 (BBB) 的人单胺氧化-B (hMAO-B) 抑制剂 (IC50= 0.067, Ki= 0.03 μM)。hMAO-B-IN-4 抑制 hMAO-A 的活性较低, IC50 值为 33.82 μM。 | |||
T60932 |
MAO-B-IN-8
|
MAO | Metabolism; Neuroscience |
MAO-B-IN-8是一种高效且可逆的单胺氧化酶-B(MAO-B)抑制剂,同时也能抑制微胶质细胞产生的神经炎症介质。该化合物专为神经退行性疾病相关研究而设计[1]。 | |||
T60671 |
MAO-B-IN-9
|
Beta Amyloid; Serotonin Transporter; Monoamine Oxidase | Neuroscience |
MAO-B-IN-9是一种可穿过血脑屏障的单胺氧化酶B MAO-B 抑制剂(IC50:0.18μM),具有有效性、选择性和时间依赖性。MAO-B-IN-9具有神经保护作用,可以防止Aβ1-42诱导的神经元细胞死亡,这可能与Aβ1-42的抗聚集作用有关。 | |||
T38034 |
MAO-IN-M30 dihydrochloride
M 30 dihydrochloride |
Monoamine Oxidase | Neuroscience |
MAO-IN-M30 dihydrochloride (M 30 dihydrochloride) 是一种口服活性,可通过血脑屏障的,脑选择性不可逆 MAO-A (IC50=37 nM) 和 MAO-B (IC50=57 nM) 抑制剂。MAO-IN-M30 dihydrochloride 是有效的铁螯合剂、自由基清除剂。MAO-IN-M30 dihydrochloride 对 Dexamethasone 诱导的脑细胞凋亡具有神经保护作用。MAO-IN-M30 dihydrochloride 在 MPTP 和 lactacystin 帕金森病模型中也显示出神经恢复活性。 | |||
T67879 |
hMAO-B-IN-5
|
MAO; Monoamine Oxidase | Metabolism; Neuroscience |
hMAO-B-IN-5 是有一种有效的、可逆的、具有选择性的人类单胺氧化酶 hMAO-B 抑制剂( IC50 :0.12 μM)。 hMAO-B-IN-5 可以透过血脑屏障,可用于对帕金森疾病的研究,是中枢神经系统疾病的治疗和诊断中都是有潜力的化合物。 | |||
T32535 |
Ladostigil
TV-3326,Ladostigil,TV 3326,TV3326,Ladostigil free base |
Antioxidant; MAO; AChE | Metabolism; Neuroscience; oxidation-reduction |
Ladostigil (Ladostigil free base) 是一种具有口服活性的胆碱酯酶和脑选择性单胺氧化酶(MAO)双重抑制剂,对 MAO-B 和 AChE 具有抑制作用,IC50值分别为37.1和31.8μM。Ladostigil 具有抗炎、抗氧化和神经保护活性,可用于研究抑郁症和阿尔茨海默病。 | |||
T80799 |
WAY-620147
|
MAO | Metabolism; Neuroscience |
WAY-620147 为N-(2-morpholinoethyl)nicotinamide的衍生物,能够抑制单胺氧化酶(Monoamine Oxidase)。WAY-620147 对MAO-A及MAO-B的IC50值分别为26 μM和55 μM,可用于研究神经系统疾病。 | |||
T6651L |
Safinamide
EMD1195686,FCE26743,FCE 26743,EMD-1195686,EMD 1195686,FCE-26743 |
MAO | Metabolism; Neuroscience |
Safinamide (FCE-26743) 是一种可逆选择性单胺氧化酶 B (IC50 0.098μM)抑制剂,可减少多巴胺的降解,也是一种谷氨酸释放抑制剂(IC50 8μM)。它还能抑制多巴胺的再摄取。 Safinamide 还能阻断钠和钙通道。 Safinamide 的潜在的其他用途可能是帕金森病、不宁腿综合征和癫痫。 | |||
T26562 |
Adarigiline
|
||
Adarigiline is a monoamine oxidase B inhibitor. | |||
T24565 |
NW-1772
NW 1772 |
||
NW-1772 is a highly potent and orally active inhibitor of monoamine oxidase B. | |||
T71728 |
NW-1772 free base
|
||
NW-1772 free base is a monoamine oxidase B inhibitor. | |||
T24430 |
MAO-B Inhibitor 58
MAO-B Inhibitor-58 |
||
MAO-B inhibitor 58 is an effective, selective, and reversible inhibitor of monoamine oxidase B. | |||
T68784 |
MD 780236
|
||
MD 780236 is a monoamine oxidase-B inhibitor. | |||
T24678 | PSB-1410 | ||
PSB-1410 is a selective and competitive monoamine oxidase B inhibitor. | |||
T69680 |
Deprenyl
|
||
Deprenyl is a selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. | |||
T10154 |
MAO-B-IN-1
|
Others | Others |
MAO-B-IN-1 is a monoamine oxidase B inhibitor and can be used for the research of neurological diseases. | |||
T28798 |
SL-25.1188
SL25.1188 |
||
SL-25.1188 is a monoamine oxidase B (MAO-B) inhibitor. SL-25.1188 is characterized by reversible binding, high brain uptake, and very slow plasma metabolism in vivo. | |||
T79229 | ETAP | Monoamine Oxidase | Neuroscience |
ETAP为一种既抑制MAO-A也抑制MAO-B的化合物,展现出抗抑郁样活性,可应用于重度抑郁症的研究领域。 | |||
T72892 |
AChE/MAO-IN-1
|
||
AChE/MAO-IN-1 是一种有效的AChE、MAO-A 和MAO-B 抑制剂,对人 AChE、MAO-B 和MAO-A 的IC50分别为 0.0248、0.0409 和 0.1108 μM。 | |||
T61463 | Monoamine oxidase/Aromatase-IN-1 | ||
Monoamine oxidase/Aromatase-IN-1 (compound 2q) is a potent dual inhibitor of monoamine oxidase (MAO) and aromatase, with IC50 values of 39 nM and 31 nM for MAO-B and aromatase, respectively. It holds significant potential for research in neurological disorders and breast cancer [1]. | |||
T61321 |
MAO-B-IN-12
|
||
MAO-B-IN-12 (Compound 16c) is a highly effective inhibitor of monoamine oxidase B (MAO-B), displaying significant potency with an IC50 value of 1.3 μM. Additionally, MAO-B-IN-12 exhibits notable neuroprotective activity [1]. | |||
T61131 | MAO-B-IN-11 | ||
MAO-B-IN-11, also known as Compound 8c, is a highly potent inhibitor of monoamine oxidase B (MAO-B), with an IC50 value of 1.3 μM. Additionally, MAO-B-IN-11 exhibits neuroprotective properties [1]. | |||
T7626L |
Budipine Hydrochloride
BY-701,BY 701,BY701,Parkinsan |
||
Budipine is a non-dopaminergic antiparkinsonian drug. The primary action of budipine is an indirect dopaminergic effect as shown by facilitation of dopamine (DA) release, inhibition of monoamine oxidase type B (MAO-B) and of DA (re) up-take and stimulatio | |||
T60660 |
MAO-B-IN-14
|
||
MAO-B-IN-14 (Compound 9) 是选择性的单胺氧化酶-B (MAO-B)抑制剂。MAO-B-IN-14 对人 MAO-B 的 IC50值为 0.95 μM,Ki 值为 0.55 μM。 | |||
T78821 |
IHC3
|
Monoamine Oxidase | Neuroscience |
IHC3是竞争性可逆MAO-B抑制剂(IC50:1.672 μM),能与MAO-B中的Cys172氨基酸结合,常用于神经系统疾病的研究。 | |||
T5470 |
LAZABEMIDE
拉扎贝胺,Ro 19-6327 |
MAO; Monoamine Oxidase | Metabolism; Neuroscience |
Lazabemide (Ro 19-6327) 是一种单胺氧化酶 B 的选择性的可逆抑制剂 ,但对 MAO-A 活性较低。它高浓度时具有抑制单胺摄取的作用,能够抑制去甲肾上腺素、血清素和多巴胺摄取,其IC50值分别为 86 μM、123 μM 和 >500 μM。它可用于研究帕金森和阿尔茨海默病。 | |||
T78859 | MAO-B-IN-23 | Monoamine Oxidase | Neuroscience |
MAO-B-IN-23(Compound 11f)作为一种MAO-B抑制剂,具有可逆性和竞争性,其IC50为1.44 μM,Ki为0.51 μM。 | |||
T79761 |
MAO-B-IN-25
|
Monoamine Oxidase | Neuroscience |
MAO-B-IN-25(化合物92)作为一种选择性MAO-B抑制剂,IC50值针对MAO-A为0.5 nM,对MAO-B为240 nM。 | |||
T60651 |
MAO-B-IN-16
|
||
MAO-B-IN-16 是单胺氧化酶 B (MAO-B) 的选择性抑制剂 (IC 50 = 1.55 μM),可用于中枢神经疾病研究,例如帕金森病。 | |||
T81866 | MAO-B-IN-27 | Monoamine Oxidase | Neuroscience |
MAO-B-IN-27(Compound 12c)是一种针对单胺氧化酶B(MAO-B)的有效且选择性的抑制剂,展现出对hMAO-B的显著抑制活性,具有8.9 nM的IC50值,用于帕金森病(PD)研究。 | |||
T78648 |
MAO-B-IN-3
|
Monoamine Oxidase | Neuroscience |
MAO-B-IN-3是一种选择性MAO-B抑制剂,具有可逆性,IC50为96 nM。该化合物还可与5-HT6R结合,Ki值为696 nM,适用于阿尔茨海默病研究。 | |||
T61830 | MAO-B-IN-10 | ||
MAO-B-IN-10 (compound 4f) is a highly potent and selective inhibitor of MAO-B (monoamine oxidase-B). It effectively penetrates the blood-brain barrier and exhibits an IC50 of 5.3 μM. This compound demonstrates the ability to inhibit self-mediated Aβ (amyloid β) aggregation by 58.2% and disaggregate it by 43.3%. Thus, MAO-B-IN-10 holds promise for Alzheimer's disease research [1]. | |||
T61603 | H3R antagonist 2 | ||
H3R antagonist 2 (Compound 23) is a multitarget histamine H3 receptor antagonist. It exhibits inhibitory effects on acetylcholinesterase, butyrylcholinesterase, and human monoamine oxidase B (hMAO B) with IC50 values of 180 nM, 880 nM, and 775 nM, respectively. With a Ki of 170 nM for hH3R, H3R antagonist 2 demonstrates favorable anti-neuropathic pain and memory-enhancing effects. Additionally, it can cross the blood-brain barrier (BBB) [1]. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3885 |
ROSIRIDIN
6'-O-Deacetylrosiridoside C,络塞定,(-)-Rosiridin |
Others; Monoamine Oxidase | Neuroscience; Others |
Rosiridin (6'-O-Deacetylrosiridoside C) 能够抑制 MAO A 和 MAO B,有潜在的抑郁症和老年性痴呆作用。它在 10 μM 时对 MAO B 的抑制率为 83.8% (pIC50=5.38)。 | |||
T13475 |
β-Aminopropionitrile
3-氨基丙腈,3-Aminopropionitrile,BAPN |
Others; Endogenous Metabolite | Metabolism; Others |
β-Aminopropionitrile (3-Aminopropionitrile) 是赖氨酰氧化酶的特异性抑制剂。 | |||
T4024 |
Norharmane
2-Azacarbazole,2,9-Diazafluorene,β-Carboline,去甲哈尔满 |
DNA; Endogenous Metabolite; Monoamine Oxidase | DNA Damage/DNA Repair; Metabolism; Neuroscience |
Norharmane (β-Carboline) 是一种有效的选择性单胺氧化酶 A (MAO-A) 抑制剂,Ki=3.34 μM。 | |||
T3158 |
Harmane
Loturine,Harman,Aribine,哈尔满碱 |
Adrenergic Receptor; Monoamine Oxidase; Imidazoline Receptor | GPCR/G Protein; Neuroscience |
Harmane (Loturine) 是一种在咖啡和烟草烟雾中发现的 β-咔啉生物碱,是有效的神经毒素,可引起严重的动作震颤和精神病学表现。它还是选择性的单胺氧化酶抑制剂,具有致突变作用,对 MAO A/B 的 IC50值分别为 0.5 和 5 μM。 | |||
T3933 |
Jatrorrhizine
Yatrorizine,neprotin,药根碱 |
MAO; 5-HT Receptor; Antibacterial; AChE | GPCR/G Protein; Metabolism; Microbiology/Virology; Neuroscience |
Jatrorrhizine (neprotin) 是一种从黄连中分离得到的生物碱,具有抗菌、抗氧化、抗疟原虫和神经保护活性。它通过抑制 uptake-2 transporter 的活性减少血清素和去甲肾上腺素的摄取。它是一种有口服活性的乙酰胆碱酯酶制剂。 | |||
TN1120 |
Osthenol
|
MAO; Monoamine Oxidase | Metabolism; Neuroscience |
Osthenol 是一种前酰化香豆素,从独活干根中分离得到。它对重组 hMAO-A 具有潜在的选择性抑制作用,IC50=0.74 µM,对 hMAO-A 和 hMAO-B 表现出较高的选择性指数。它是一种可逆的,选择性的竞争性人单胺氧化酶-A(hMAO-A)抑制剂 (Ki=0.26 µM)。 | |||
T40244 |
Methyl citrate
|
||
Methyl citrate, obtained from Opuntia ficus-indica var. saboten Makino fruits, serves as a potent Monoamine oxidase B (MAO-B) inhibitor with an IC50 value of 0.23 mM. | |||
TN3693 | Confluentic acid | Others | Others |
Confluentic acid shows selective inhibition of Monoamine oxidase B with IC50 value of 0.22 microM. | |||
TN2790 |
2'-O-Methylperlatolic acid
|
MAO | Metabolism; Neuroscience |
2'-O-Methylperlatolic acid and confluentic acid are monoamine oxidase B inhibitors in a Brazilian plant, Himatanthus sucuuba. | |||
TN3116 |
5-Hydroxy-1-methoxyxanthone
|
MAO; Antifection | Metabolism; Microbiology/Virology; Neuroscience |
5-Hydroxy-1-methoxyxanthone, 1,5-dihydroxyxanthone and 6-deoxyjacareubin are all antifungal against Cladosporium cucumerinum, while they show differing degrees of inhibition of monoamine oxidase A and B. | |||
TN3726 | Cudraflavone B | IκB/IKK; MAO; ROS; Akt; COX; PI3K; Nrf2; Autophagy | Autophagy; Cytoskeletal Signaling; Immunology/Inflammation; Metabolism; Neuroscience; NF-κB; PI3K/Akt/mTOR signaling |
Cudraflavone B has anti-proliferative activity, mouse brain monoamine oxidase (MAO) inhibitory effects, apoptotic actions in human gastric carcinoma cells and mouse melanoma cells, and hepatoprotective activity. It may be a lead for the development of a potential candidate for human oral squamous cell carcinoma cells. | |||
T79979 |
Methyl piperate
|
Monoamine Oxidase | Neuroscience |
Methylpiperate,一种胡椒碱类生物碱,展现出显著的MAO抑制活性(IC50 3.6 μM)。该化合物对MAO-B的选择性抑制作用(IC50 1.6 μM)优于对MAO-A(IC50 27.1 μM),因此可用于治疗精神障碍。 | |||
TC0022 |
Desoxypeganine
Deoxypeganine |
AChE | Neuroscience |
Desoxypeganine (Deoxypeganine) 是胆碱酯酶的抑制剂。它优先作用于丁酰胆碱酯酶,作为单胺氧化酶 A 而不是单胺氧化酶 B 的选择性抑制剂。它在酒精滥用的药理学治疗中的潜在用途,以减少酒精滥用者的渴望和抑郁,并且也可能有用作为戒烟辅助。 | |||
T37911 |
cis-Resveratrol
顺式白藜芦醇,(Z)-Resveratrol |
||
Resveratrol is a potent phenolic antioxidant found in grapes, red wine, and various berries that also has antiproliferative and anti-inflammatory activity. cis-Resveratrol is the double bond isomer of trans-resveratrol, the more often studied and naturally abundant of the two resveratrol isomers. cis-Resveratrol exhibits antioxidant activity in the µM range similar to that observed with trans-resveratrol. It blocks production of reactive oxygen species (ROS) by inhibition of NAD(P)H oxidase ... |